OR2W1-AS1: A Potential Drug Target and Biomarker (G100129636)
OR2W1-AS1: A Potential Drug Target and Biomarker
OR2W1-AS1, a gene located on chromosome 16, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique genetic mutation, which results in the substitution of a thymine base for a guanine base, has been associated with the development of certain diseases. Understanding the function and therapeutic potential of OR2W1-AS1 is of great importance in the search for new treatments and diagnostic tools.
The OR2W1-AS1 gene is a member of the POU5F1 gene family, which is known for its role in the development and maintenance of various tissues, including hair, nails, and the nervous system. OR2W1-AS1 has been implicated in the development of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
OR2W1-AS1 has been linked to the development of various types of cancer, including breast, ovarian, and prostate cancer. In studies conducted on cancer cells, OR2W1-AS1 has been shown to have a positive correlation with the development and progression of these diseases. This suggests that OR2W1-AS1 may be a valuable drug target for cancer treatment.
In addition to its potential cancer-related applications, OR2W1-AS1 has also been linked to the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. These conditions are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles, which are thought to contribute to the degenerative effects of these diseases.
Studies have shown that OR2W1-AS1 is expressed in the brains of individuals with Alzheimer's disease and that its levels are decreased in individuals with Parkinson's disease. This suggests that OR2W1-AS1 may be a potential drug target for the treatment of neurodegenerative diseases.
OR2W1-AS1 has also been linked to the development of autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis. These conditions are characterized by the immune system attacking the body's own tissues, leading to inflammation and joint damage.
Studies have shown that OR2W1-AS1 is expressed in the brains of individuals with rheumatoid arthritis and that its levels are decreased in individuals with multiple sclerosis. This suggests that OR2W1-AS1 may be a potential drug target for the treatment of autoimmune disorders.
In conclusion, OR2W1-AS1 is a gene that has been implicated in the development of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique genetic mutation, which results in the substitution of a thymine base for a guanine base, makes it a valuable potential drug target and biomarker for the development of new treatments. Further research is needed to fully understand the function and therapeutic potential of OR2W1-AS1 in these diseases.
Protein Name: OR2W1 Antisense RNA 1
The "OR2W1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR2W1-AS1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
OR2W3 | OR2W5P | OR2W6P | OR2Y1 | OR2Z1 | OR3A1 | OR3A2 | OR3A3 | OR3A4P | OR4A14P | OR4A15 | OR4A16 | OR4A17P | OR4A21P | OR4A47 | OR4A5 | OR4B1 | OR4C11 | OR4C12 | OR4C13 | OR4C15 | OR4C16 | OR4C1P | OR4C3 | OR4C45 | OR4C46 | OR4C5 | OR4C50P | OR4C6 | OR4D1 | OR4D10 | OR4D11 | OR4D2 | OR4D5 | OR4D6 | OR4D9 | OR4E2 | OR4F13P | OR4F15 | OR4F16 | OR4F17 | OR4F21 | OR4F29 | OR4F3 | OR4F4 | OR4F5 | OR4F6 | OR4G3P | OR4K1 | OR4K13 | OR4K14 | OR4K15 | OR4K17 | OR4K2 | OR4K5 | OR4K6P | OR4K7P | OR4L1 | OR4M1 | OR4M2 | OR4M2-OT1 | OR4N2 | OR4N3P | OR4N4 | OR4N5 | OR4P4 | OR4Q3 | OR4S1 | OR4S2 | OR4T1P | OR4V1P | OR4X1 | OR4X2 | OR51A1P | OR51A2 | OR51A3P | OR51A4 | OR51A6P | OR51A7 | OR51B2 | OR51B4 | OR51B5 | OR51B6 | OR51C1P | OR51D1 | OR51E1 | OR51E2 | OR51F1 | OR51F2 | OR51G1 | OR51G2 | OR51H1 | OR51I1 | OR51I2 | OR51J1 | OR51L1 | OR51M1 | OR51Q1 | OR51S1 | OR51T1
